Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol
JBI Evidence Synthesis · 2026-11 · 24 (11) · 2385-2397
DOI: 10.11124/jbies-25-00506 ↗Kurz gefasst
Scoping Review in der Zeitschrift JBI Evidence Synthesis, online erschienen am 20.10.2026. Verfasst von Abigail M Day-Sharman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Adelaide University, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Rare Diseases, Technology Assessment, Biomedical, Practice Guidelines as Topic. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
This scoping review will identify methodological guidance relevant to systematic reviews (SRs), clinical practice guidelines (CPGs), and health technology assessments (HTAs) for rare diseases, and examine methodological challenges associated with their development.
Introduction
Rare diseases affect approximately 400 million people worldwide. However, individual rarity limits health care provider knowledge and awareness and, subsequently, management of rare diseases is hindered by diagnostic delays, limited treatment options, and high treatment costs. Heterogeneous populations and sparse, low-quality evidence also impede research quality and render traditional evidence evaluation methods ill-suited to rare diseases. Consequently, existing methodological frameworks guiding evidence-based development of SRs, CPGs, and HTAs may not appropriately consider contextual nuances of rare diseases. Eligibility criteria: This scoping review will consider both peer-reviewed and gray literature relevant to methodological guidance for SRs, CPGs, and HTAs. Eligible sources will focus on rare diseases collectively, or specific conditions that meet the criteria of a rare disease, and address at least 1 aspect of methodology used to develop SRs, CPGs, or HTAs relevant to rare disease contexts.
Methods
The 3-step search strategy began with an exploratory PubMed search to refine terms, which will be followed by comprehensive searches in MEDLINE, Embase, Scopus, and the Cochrane Library. Gray literature will be searched via Google Scholar, Orphanet, the World Health Organization Institutional Repository for Information Sharing, the International Network of Agencies for Health Technology Assessment, and the National Institute for Health and Care Excellence. Identified sources will be independently screened, selected, and extracted by multiple reviewers. Data will be analyzed using descriptive statistics and qualitative content analysis, then presented in summary tables and summarized descriptively. Review registration: OSF https://osf.io/mrfev
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Adelaide University, Adelaide, SA, Australia.
- Knowledge Institute of the Dutch Association of Medical Specialists, Utrecht, The Netherlands.
- Adelaide Health Technology Assessment (AHTA), School of Public Health, Adelaide University, Adelaide, SA, Australia.
- Amsterdam Reproduction & Development, Amsterdam Public Health, Amsterdam UMC, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands.
- European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA), Clinical Genetics Department, Robert Debré University Hospital, Paris, France.
- Queensland Ambulance Service, Department of Health, Queensland Government, Brisbane, QLD, Australia.
ORCID-Profile: Abigail M Day-Sharman, Danielle Pollock, Tracy Merlin, Mirthe J Klein Haneveld, Cindy Stern, Brendan V Schultz, Federico Germini, Konstantinos Margetis, Iméze J Hieltjes, Zachary Munn
Zitieren
APA
Day-Sharman, A. M., Pollock, D., Barker, T. H., van der Lee, J. H., Merlin, T., Klein Haneveld, M. J., Stern, C., Schultz, B. V., Germini, F., Margetis, K., Hieltjes, I. J., & Munn, Z. (2026). Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol. JBI Evidence Synthesis, 24(11), 2385-2397. https://doi.org/10.11124/jbies-25-00506
Vancouver
Day-Sharman AM, Pollock D, Barker TH, van der Lee JH, Merlin T, Klein Haneveld MJ, et al. Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol. JBI Evidence Synthesis. 2026;24(11):2385-2397. doi:10.11124/jbies-25-00506
BibTeX
@article{DaySharman2026,
author = {Day-Sharman, Abigail M and Pollock, Danielle and Barker, Timothy H and van der Lee, Johanna H and Merlin, Tracy and Klein Haneveld, Mirthe J and Stern, Cindy and Schultz, Brendan V and Germini, Federico and Margetis, Konstantinos and Hieltjes, Iméze J and Munn, Zachary},
title = {Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol},
journal = {JBI Evidence Synthesis},
year = {2026},
volume = {24},
number = {11},
pages = {2385--2397},
doi = {10.11124/jbies-25-00506}
}
EUVIMED